Project Grant R42GM151928
Award Date
9/12/24
Completion Date
9/11/25
Dollars Obligated
$350K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Florida, USA
Similar Awards
This $305,000 project grant awarded by the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports the development of a clinical decision support system (CDSS) called Sepsis FLO. The CDSS is designed to precisely guide blood volume diagnosis and treatment for sepsis patients. Key activities include: 1) Developing an alpha prototype of the CDSS through user-centered design; 2) Validating three functional...
This $403,750 Project Grant award, funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859), aims to unravel the relationships between gut and blood microbial signatures and immune responses in sepsis patients. The research will use a meta-systems approach to integrate gut microbial community profiling, metabolomics, measures of intestinal permeability, and blood microbial signatures with immune phenotypes...
This $700,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the clinical validation of Prenosis, Inc.'s IMMUNIX platform, a precision medicine endotyping solution for sepsis. The project aims to: 1) validate the IMMUNOSCAN multiplex rapid test and mapping functions to Luminex immunoassays; 2) validate a parsimonious model for point-of-care endotyping; and 3) demonstrate the ability to...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $455,000.00 to the Children's Research Institute to develop new therapeutic protocols for pediatric sepsis. The key objectives are to: 1) use an AI-guided early identification tool for sepsis, 2) perform sepsis phenotyping and create digital twin patient models to predict personalized treatment responses, and 3) develop an...
The National Institute of General Medical Sciences (NIGMS) has awarded a 5-year, $1,091,250 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Wake Forest University to advance the biomedical applications of reactive sulfur and selenium species. The research aims to overcome barriers in the effective delivery and detection of these reactive biomolecules, which have shown promise for therapeutic and diagnostic applications in areas like cancer, neurodegenerative...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $166,204 to Dr. Nicholas P. Semenkovich and the Medical College of Wisconsin to develop and advance cell-free DNA as a novel biomarker with predictive and prognostic roles in sepsis. The primary research goal is to use machine learning methods to identify septic patients at risk of complications, and test these...
The National Institute of General Medical Sciences (NIGMS) awarded a $218,622 Project Grant to Vitan-Biotech LLC on September 22, 2023 under the Biomedical Research and Research Training program (CFDA 93.859). The grant will fund the development of an integrated pipeline to rapidly discover and characterize selective, high-affinity nanobodies against defined G protein-coupled receptors (GPCRs) that are important for neurological disorders like schizophrenia, pain, Parkinson's, Alzheimer's, and...
The National Institute of General Medical Sciences (NIGMS) awarded a $314,363 Project Grant under CFDA 93.859 (Biomedical Research and Research Training) to Delineate Inc., a for-profit woman-owned small business, for the period of April 1, 2025 to March 31, 2026. The project, titled "DELINEATEQSP: ACCELERATING QUANTITATIVE SYSTEMS PHARMACOLOGY MODEL BUILDING AND REPURPOSING", aims to develop an innovative platform that uses large language models (LLMs) to accelerate the building and...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $684,206 to the University of Maryland, Baltimore to develop multimodal nanoparticle-based immunotherapies for the treatment of sepsis. The key objectives are to: 1) evaluate the immunomodulatory properties of select nanoparticles to maximize therapeutic efficacy in a sepsis model, 2) identify the cellular and...
This $300,892 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to elucidate the biosynthesis and identify novel dehydrated nonribosomal peptides produced by Streptomyces bacteria. The project aims to characterize the enzymes and biosynthetic pathways involved in the production of these natural products, which have potential therapeutic applications due to their...